An older study of patients with small cell lung cancers by van de Pol et al [21] also showed that while serum NSE levels rose with the development of metachronous brain metastases, changes in NSE levels were not specific to intracranial disease activity. This evidence concerns the gene ENO2 and small cell lung carcinoma.